Safety and efficacy of aficamten in patients with non‐obstructive hypertrophic cardiomyopathy: A 36‐week analysis from FOREST‐HCM. - Masri, Ahmad; Barriales‐Villa, Roberto; Elliott, Perry; Nassif, Michael E.; Oreziak, Artur; Owens, Anjali T.; Tower‐Rader, Albree; Heitner, Stephen B.; Kupfer, Stuart; Malik, Fady I.; Melloni, Chiara; Meng, Lisa; et al. (European Journal of Heart Failure, 2024)